Senseonics Holdings, Inc. (SENS) News
Filter SENS News Items
SENS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest SENS News From Around the Web
Below are the latest news stories about Senseonics Holdings Inc that investors may wish to consider to help them evaluate SENS as an investment opportunity.
Senseonics Holdings (SENS) Gets a Hold Rating from BTIGIn a report released today, Marie Thibault from BTIG reiterated a Hold rating on Senseonics Holdings (SENS – Research Report). The company's shares closed last Wednesday at $1.83, close to its 52-week low of $1.40. According to TipRanks.com, Thibault is a 5-star analyst with an average return of 22.6% and a 38.7% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Irhythm Technologies. The word on The Street in general, suggests a Hold analyst consensus rating for Senseonics Holdings with a $1.90 average price target. |
Analysts’ Opinions Are Mixed on These Technology Stocks: Avid Technology (AVID), Lattice Semiconductor (LSCC) and Senseonics Holdings (SENS)Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Avid Technology (AVID – Research Report), Lattice Semiconductor (LSCC – Research Report) and Senseonics Holdings (SENS – Research Report). Avid Technology (AVID) In a report released today, Steve Frankel from Colliers Securities maintained a Hold rating on Avid Technology. The company's shares closed last Tuesday at $29.00. According to TipRanks.com, Frankel is a 2-star analyst with an average return of -5.5% and a 36.2% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Apollo Medical Holdings, Chembio Diagnostics, and Semler Scientific. |
Senseonics ticks up on Q4 earnings beatSenseonics (NYSE:SENS) shares ticked up today on fourth-quarter results that came in ahead of the consensus forecast. The Germantown, Maryland-based company posted revenues of $4 million for the three months ended Dec. 31, 2021, representing sales growth of 2.6% from the same period in 2020. Adjusted to exclude one-time items, earnings per share were 1¢, […] The post Senseonics ticks up on Q4 earnings beat appeared first on Drug Delivery Business . |
Senseonics Holdings (SENS) Beats Q4 Earnings and Revenue EstimatesSenseonics (SENS) delivered earnings and revenue surprises of 133.33% and 0.20%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial ResultsGERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter and full year ended December 31, 2021. Recent Highlights & Accomplishments: Received approval from the Food and Drug Administration (FDA) for the Eversense® E3 CGM System, offering patients: Fu |
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q4 2021 Results - Earnings Call TranscriptNo summary available. |
Senseonics swings to net income in Q4 as its beats on the top and bottom linesGlucose monitoring system manufacturer Senseonics Holdings (SENS) swung to Q4 2021 net income amidst a modest increase in revenue. |
Senseonics GAAP EPS of -$0.72 beats by $0.22, revenue of $13.67M beats by $0.05MSenseonics press release (SENS): FY GAAP EPS of -$0.72 beats by $0.22.Revenue of $13.67M beats by $0.05M.Shares -2.8%.FY 2022 Guidance: Global net revenue to Senseonics for the… |
Senseonics Q4 2021 Earnings PreviewSenseonics (NYSE:SENS) is scheduled to announce Q4 earnings results on Tuesday, March 1st, after market close.The consensus EPS Estimate is -$0.03 (+92.7% Y/Y) and the consensus… |
AllScripts Healthcare (MDRX) Q4 Earnings and Revenues Surpass EstimatesAllScripts (MDRX) delivered earnings and revenue surprises of 154.84% and 0.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |